Zentalis Pharmaceuticals Email Formats

Biotechnology Research • 10275 Science Center Dr, Suite 200, United States • 101-200 Employees

Zentalis Pharmaceuticals Email Formats

Zentalis Pharmaceuticals uses 4 email formats. The most common is {first name}{last name} (e.g., johndoe@zentalis.com), used 75% of the time.

Format	Example	Percentage
{first name}{last name}	johndoe@zentalis.com	75%
{first initial}{last name}	jdoe@zentalis.com	21.4%
{last name}{last name}	doedoe@zentalis.com	2.4%
{last name}	doe@zentalis.com	1.2%

Key Contact at Zentalis Pharmaceuticals

Nush Jitpraphai

Executive Director/Head of Product Development

Mobile @zentalis.com

Company overview

Headquarters	10275 Science Center Dr, Suite 200, San Diego, California 92121, US
Phone number	+12124333791
Website	zentalis.com
NAICS	541714
Employees	101-200
Socials

About Zentalis Pharmaceuticals

Zentalis® Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1+ platinum-resistant ovarian cancer (PROC). Azenosertib is being evaluated as a monotherapy and in combination across multiple tumor types in clinical trials and has broad franchise potential. In clinical trials, azenosertib has been well tolerated and has demonstrated anti-tumor activity as a single agent across multiple tumor types. The Company is also leveraging its extensive experience and capabilities to translate its science to advance research on additional areas of opportunity for azenosertib outside PROC.

Employees by Management Level

Total employees: 101-200

Seniority

Employees

Director

Senior

Vice President

Employees by Department

Zentalis Pharmaceuticals has 68 employees across 11 departments.

Departments

Number of employees

Funding Data

Explore Zentalis Pharmaceuticals's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2023-07-15	14	$235,500,000

Funding Insights

$235,500,000

Total funding amount

$235,500,000

Most recent funding amount

Number of funding rounds

Zentalis Pharmaceuticals Tech Stack

Discover the technologies and tools that power Zentalis Pharmaceuticals's digital infrastructure, from frameworks to analytics platforms.

Cloudflare

CDN

Google Hosted Libraries

CDN

jQuery CDN

CDN

reCAPTCHA

Security

jQuery

JavaScript libraries

Google Tag Manager

Tag managers

GoDaddy

Hosting

Apple iCloud Mail

Webmail

HTTP/3

Miscellaneous

HSTS

Security

Open Graph

Miscellaneous

core-js

JavaScript libraries

Frequently asked questions

Zentalis Pharmaceuticals is located in 10275 Science Center Dr, Suite 200, US.

You can reach Zentalis Pharmaceuticals at +12124333791.

Zentalis Pharmaceuticals has approximately 101-200 employees. The company continues to grow its workforce to support its business operations and expansion.

Zentalis Pharmaceuticals has raised a total of $235,500,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at Zentalis Pharmaceuticals

Nush Jitpraphai

Executive Director/Head of Product Development

Mobile @zentalis.com

4.8

40,000 users